Minh Truong

10PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 23, 2026
Real-World Comparison of Abiraterone Acetate Versus Docetaxel in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Cohort Study From Vietnam.

|Nov 28, 2025
Real-World Effectiveness and Safety of Ribociclib Plus Aromatase Inhibitors in Patients with HR+/HER2- Metastatic Breast Cancer: A Multicenter Experience from Vietnam.

Hoa Thi Nguyen, Quang Van Le, Huyen Thi Phung

|Oct 22, 2025
Real-World Evidence for First-Line afatinib in Advanced Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations Other than G719X/L861Q/S768I.

Thanh Ha Vu, Hoa Thai Thi Nguyen, To Van Ta

|Oct 21, 2025
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam.

Cam Phuong Pham, Hung Kien Do, Anh Tu Do

|May 25, 2025
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam.

Van Luan Pham, Cam Phuong Pham, Thi Thai Hoa Nguyen

|Dec 18, 2024
The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases.

Thai Van Pham, Thanh Ha Vu, Hoa Thai Thi Nguyen

Pageof 2

Frequent Collaborators

4 joint publications

Van Luan Pham

3 joint publications

Hung Kien Do

3 joint publications

Thanh Ha Vu

2 joint publications

Long Thanh Nguyen